Eflapegrastim not checked
Spectrum Pharmaceuticals, Inc · SPI-2012 · HM10460A
FollowEvery change as it happens, and a Monday email
Trials
1 active
5 in total
What this is
- How it works
- Leukocyte Growth Factor FDA class
- How it’s given
- “Eflapegrastim supplied in prefilled, single-use syringes for SC injection.”In the company’s words, NCT04570423 on ClinicalTrials.gov
- Tested for
- Solid Tumors, Lymphoma
- Main trialPhase 2
- “The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated with myelosuppressive chemotherapy.”In the company’s words, NCT04570423 on ClinicalTrials.gov
- Other names
- SPI-2012 · Rolontis · HM10460A
Other drugs for Solid Tumors
- AvelumabEMD Serono Research & Development Institute, Inc. · Phase 3
- AlectinibRoche · Phase 3
- AtezolizumabRoche · Phase 3
- AU-011Aura Biosciences · Phase 3
- BevacizumabRoche · Phase 3
- CadonilimabAkeso · Phase 3
Coming up1
- Oct 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Oct 2027 | A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy | |
| Phase 3Completed | 24 Jan 2018 | SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) | |
| Phase 3Completed | 8 Jun 2018 | SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide | |
| Phase 2Completed | 12 Aug 2014 | Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer | |
| Phase 1Completed | 16 Jul 2024 | Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026